Evidence map›Paper›PMID 41847272›Full record

ArticleNeuro-ophthalmology (Aeolus Press)2026

Characterisation of Ocular Manifestations in Patients with Multiple Sclerosis in Colombia: A Multicentric Study.

Alejandro Manrique-Samer, Carlos Cifuentes-González, José Vicente Álvarez-Martínez, William Rojas-Carabali, María Camila Cortes-Albornoz, Alberto Vélez Van-Meerbeke, Paola Andrea Ortiz-Salas, Adriana Casallas-Vanegas, Claudia M Guío-Sánchez, Juanita Cardona-López and 2 more

Abstract read
In one paragraph

Article in Neuro-ophthalmology (Aeolus Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alejandro Manrique-SamerSemillero de investigación Semineuros, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0009-0003-5777-4963
Carlos Cifuentes-GonzálezGrupo de investigación en Neurociencias NeURos, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-2703-0977
José Vicente Álvarez-MartínezSemillero de investigación Semineuros, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
William Rojas-CarabaliGrupo de investigación en Neurociencias NeURos, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-9976-8989
María Camila Cortes-AlbornozGrupo de investigación en Neurociencias NeURos, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0000-0003-0733-5105
Alberto Vélez Van-MeerbekeGrupo de investigación en Neurociencias NeURos, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-8889-4170
Paola Andrea Ortiz-SalasGrupo de investigación en Neurociencias NeURos, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-8052-6103
Adriana Casallas-VanegasNeurology Department, Cayre Multiple Sclerosis Center, Bogotá, Colombia.ORCID https://orcid.org/0000-0003-4711-8148
Claudia M Guío-SánchezDepartamento de Neurología, Hospital Universitario Mayor Méderi, Bogotá, Colombia.
Juanita Cardona-LópezSemillero de investigación Semineuros, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0009-0004-3888-3870
Germán Mejía-SalgadoGrupo de investigación en Neurociencias NeURos, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-1241-0715
Alejandra de-la-TorreSemillero de investigación Semineuros, Centro de Neurociencia NeuroVitae, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.ORCID https://orcid.org/0000-0003-0684-1989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To describe the ocular manifestations in multiple sclerosis (MS) patients in Colombia. We conducted a retrospective observational study of electronic medical records from MS patients evaluated at three referral centres in Bogotá, Colombia, between 2013 and 2020. Inclusion criteria comprised adult patients diagnosed with MS, confirmed by neurologists following the 2017 McDonald criteria. Data on patient demographics, MS phenotypes, ocular symptoms, clinical findings, and treatments were collected from the clinical charts and analysed using descriptive statistics. Optic neuritis was the most common ocular condition (34.1%), followed by glaucoma (6.1%) and nystagmus (4.5%). Other reported conditions included nerve palsies, uveitis, retinal vasculitis, and scleritis (0.8%-2.3%). Of the 618 MS patients reviewed, 132 (19.4%) had ocular manifestations reported. Most were female (71.2%), with a mean age of 34.9 ± 11.8 years. Ocular manifestations were frequent in patients with MS in this Colombian sample. Optic neuritis is the most common, but glaucoma and other ocular pathologies can also develop. Therefore, due to the frequent co-occurrence of these conditions, patients with MS or optic neuritis should have rigorous follow-up care coordinated between ophthalmologists and neurologists.

Indexed as

EpidemiologyMultiple sclerosisNeuromyelitis opticaOphthalmologyoptic neuritis

Identifiers

PMID41847272
PMCPMC12990931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.